Culturing and Expansion of “Clinical Grade” Precursors Cells from the Fetal Human Central Nervous System
- 15 July 2013
- book chapter
- Published by Springer Nature
- Vol. 1059, 65-77
Abstract
NSCs have been demonstrated to be very useful in grafts into the mammalian central nervous system to investigate the exploitation of NSC for the therapy of neurodegenerative disorders in animal models of neurodegenerative diseases. To push cell therapy in CNS on stage of clinical application, it is necessary to establish a continuous and standardized, clinical grade (i.e., produced following the good manufacturing practice guidelines) human neural stem cell lines. In this chapter, we illustrate some of the protocols routinely used into our GMP cell bank for the production of “clinical grade” human neural stem cell lines.Keywords
This publication has 5 references indexed in Scilit:
- Translating Stem Cell Studies to the Clinic for CNS Repair: Current State of the Art and the Need for a Rosetta StoneNeuron, 2011
- Stem cells in human neurodegenerative disorders — time for clinical translation?Journal of Clinical Investigation, 2010
- Stem cell‐based cell therapy in neurological diseases: A reviewJournal of Neuroscience Research, 2009
- Adult Neural Stem Cells2008
- Generation of Neurons and Astrocytes from Isolated Cells of the Adult Mammalian Central Nervous SystemScience, 1992